BFM
IRON icon

Boothbay Fund Management’s Disc Medicine IRON Stock Holding History

Boothbay Fund Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-112,500
Closed -$7M – 1698
2024
Q1 		$7M Buy
+112,500
New +$7.29M 0.13% 136
2023
Q4 		– Sell
-31,200
Closed -$1.47M – 1815
2023
Q3 		$1.47M Buy
+31,200
New +$1.56M 0.03% 606

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Boothbay Fund Management's IRON Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in Disc Medicine (IRON) in Q1 2026: 21,378 shares worth $1.37M. The stake represents 0.02% of the portfolio and ranks #796 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in IRON as recently as Q1 2024.

Boothbay Fund Management first reported a position in IRON in Q1 2021 and has held it in 11 quarters since. The position peaked at $2.49M in Q4 2023. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

  • Boothbay Fund Management held 21,378 shares of Disc Medicine worth $1.37M as of Q1 2026.
  • Disc Medicine was a new Boothbay Fund Management position in Q1 2026.
  • Disc Medicine made up 0.02% of Boothbay Fund Management's portfolio in Q1 2026, its #796 holding.
  • Boothbay Fund Management first reported a position in Disc Medicine in Q1 2021 and has held it in 11 quarters since.
  • Boothbay Fund Management's Disc Medicine position peaked at $2.49M in Q4 2023.
  • 203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.